Incidence and Prognostic Values in Human Epidermal Growth Factor Receptor 2-Low Expression Metastatic Breast Cancer in Southeast Asian Population: A 10-Year Retrospective Study.
Article in JCO Global Oncology (September 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis
Article in Frontiers in Oncology (August 2024)
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine
Article in Breast Cancer (August 2024)